Next Article in Journal
Chemical Composition of Four Essential Oils of Eugenia from the Brazilian Amazon and Their Cytotoxic and Antioxidant Activity
Next Article in Special Issue
A Reassessment of the Marrubium Vulgare L. Herb’s Potential Role in Diabetes Mellitus Type 2: First Results Guide the Investigation toward New Horizons
Previous Article in Journal
Essential Oil from Piper aduncum: Chemical Analysis, Antimicrobial Assessment, and Literature Review
Previous Article in Special Issue
Medicinal Plants Used for Neuropsychiatric Disorders Treatment in the Hauts Bassins Region of Burkina Faso
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

A Review on Ethno-Medicinal and Pharmacological Activities of Sphenocentrum jollyanum Pierre

by
Olubukola Sinbad Olorunnisola
,
Olumide Samuel Fadahunsi
* and
Peter Adegbola
Department of Biochemistry, Faculty of Basic Medical Sciences, Ladoke Akintola University of Technology, Ogbomoso, PMB 4000, Oyo State, Nigeria
*
Author to whom correspondence should be addressed.
Medicines 2017, 4(3), 50; https://doi.org/10.3390/medicines4030050
Submission received: 10 June 2017 / Revised: 27 June 2017 / Accepted: 28 June 2017 / Published: 3 July 2017
(This article belongs to the Special Issue Plant Medicines for Clinical Trial)

Abstract

:
Sphenocentrum jollyanum Pierre is a member of a diverse family of plants known as Menispermaceae. They are famous for a plethora of important biological functions. S. jollyanum is a shrub native to the tropical forest zones of West Africa and thrives in deep shade. It is widely cultivated in Cameroun, Sierra Leone, Nigeria, Ghana, and Côte d’Ivoire. S. jollyanum is employed in folk medicine as a cure for wounds, fever, coughs, high blood pressure, breast tumor, constipation, and as an aphrodisiac. Phytochemical investigations revealed that the plant is a rich source of secondary metabolites such as annin, alkaloids, saponins, and flavonoids. Pharmacological activities include anti-diabetic, anti-inflammatory, anti-bacterial, anti-viral, anti-malarial, angiogenic, and anxiogenic. Thus, this present review summarizes the phytochemical and nutritional constituents and important biological studies on various crude extracts, fractions, and isolated principles of all morphological organs of S. jollyanum.

1. Introduction

Globally, the employment of medicinal plants as a substitute for orthodox drugs in the management of various diseases has been increasing due to the unavailability of modern health facilities, relative availability of medicinal herbs, poverty, and recent revelations that they possess active compounds that may be responsible for different biological and pharmacological actions [1]. According to Newman and Cragg [2], natural materials are the source of about two -third of all drugs developed in the past three decades. According to a World Health Organization (WHO) report, it is estimated that close to 80% of the people living in the third world nations of the world depend on traditional and complementary medicines for their basic health care [3]. Thus, this review is aimed at elucidating the traditional and biological importance of Sphenocentrum jollyanum.
S. jollyanum Pierre is a member of the plant family Menispermaceae (Table 1). These are diverse group of plants which are popular for important biological activities. S. jollyanum is a shrub native to the tropical forest zones of West Africa and is widely distributed in Sierra Leone, Nigeria, Ghana, Ivory Coast, and Cameroun [4]. It is extensively employed in folkloric medicine in the management of various ailments. S. jollyanum is commonly known locally as “Aduro kokoo” (red medicine), “Okramankote” (dog’s penis), and “Krakoo” among the Akan and Asante tribes of Ghana. In South-Western Nigeria, the plant is traditionally known as Akerejupon or Ajo, Oban abe in Republic of Benin, and Ouse-abe in Côte d’Ivoire [5].

2. Plant Description

Sphenocentrum jollyanum (Figure 1) is a perennial under growth of dense forest, which thrives in deep shade, from sea-level up to 400 m altitude. It is mostly found in regions withmean annual rainfall of 1800 mm or more, mean minimum temperature of 20 °C, and mean maximum of 29 °C. It grows to an average height of about 1.5 m, with few scanty branches. S. jollyanum leaves are wedge-shaped, about 5–12 cm wide, smooth onboth sides, and can grow up to about 20 cm long with a small-arrowed apex [6,7]. The fruit (Figure 2) occurs as clusters, ovoid-ellipsoid, with a single large oval-shaped seed. It is fleshy, edible, and bright yellow or orange when ripe [8,9]. The roots are visibly bright yellow and are characterized by a sour acidic taste that causes things eaten thereafter to taste sweet [8].

3. Ethno-Medicinal Uses

Different parts of S. jollyanum are traditionally employed in folkloric medicine. In Ghana, the root of the plant is widely used by the men as an aphrodisiac. It is steeped in alcohol for few days to allow extraction of some constituents, which is thereafter drank as bitters to strengthen penile erection, and this effect is known to be long-lasting [10,11].
It has been documented in several literature studies that the root is employed for its effectiveness in stimulating the central nervous system (CNS), the management of mental and inflammatory disorders, pain and depression [12]. The dried, powdered root is used in combination with some anti-malarial plant as panacea for fever and muscular pains. Aerial parts of the plant (leafy twigs and fruits) are vastly employed in the treatment of chronic wounds, feverish conditions, and coughs when combined with Piper guineense (West African pepper) and lime juice [8,9].
In Nigeria, the roots are chewed in traditional medicine to relieve constipation, promote appetite, and increase digestion. All morphological organs of S. jollyanum are important ingredients in the management of sickle cell disease (SCD) [8]. Traditional healers in Ghana and Côte d’Ivoire have also reported the roots to possess medicinal properties against high blood pressure, breast tumor, irregular menstrual cycle, and diabetes mellitus [7,13,14,15,16]. Furthermore, the powdered roots are eaten in combination with Aframomum melegueta (alligator pepper) seeds, salt, and Elaeis guineensis (African oil palm) in the management of abdominal discomfort [17]. The charred fruits are used in the treatment of fibroids and as edible anti-fatigue snack [9,18]. It is also reported that the leaves decoctions are used in expelling intestinal parasites and to stop spitting of blood [15].

4. Phytochemical and Proximate Analysis

The majority of the reported biological and pharmacological activity of S. jollyanum extracts (Table 2) has been attributed to their bioactive principles and constituent phytochemicals. A detailed phytochemical analysis of the ethanol root extract of S. jollyanum revealed that it contains compounds such as terpenoids and flavonoids, while alkaloids are reported to be the most dominant chemical constituents [19]. Phytochemical investigation by Nia et al. [4] revealed the presence of tannins, saponins, terpenes, and alkaloids in the different fractions of methanol extracts of the stem bark. The chloroform fraction was found to be the most active of all fractions, and it tested positive to the test of flavonoids and alkaloids. In the submission of Aboabaand Ekundayo [20], detailed analysis of the essential oil of S. jollyanum root using gas chromatography-mass spectrometry analysis (GC-MS) revealed a total of 19 compounds (α-pinene, α-ylangene, guaia-6,9-diene-4α-ol, globulol, guaiene-11-ol, α-eudesmol, isocaryophyllene, aromadendrene, selina-4(15),6-dien E-β-isocaryophyllene, γ-terpinene, γ-humulene, epi-zonarene, δ-amorphene, 1,8-cineol,camphene, B-pinene, p-cymene, d3-carene, Figure 3) consisting of monoterpenoids (33.5%) and sesquiterpenoids (56.3%), while (10.2%) of the total oil constituents remain unidentified. Phytochemistry of the seed extracts by Ibironke et al. [21] revealed the bio-availability of flavonoids, alkaloids, and saponins, while phylobatannin and free anthraquinone were not present. Proximate analysis of the seed extract showed the crude fat, moisture, crude protein, carbohydrate, ash, and fiber contents to be 9.65%, 16.70% 48.09%, 16.79%, 3.26%, and 5.51%, respectively, while the energy value was 1460 kcal/100 kg. This suggests that the fruits are an important source of nutrients and energy [21]. Interestingly, the flame photometric and atomic absorption spectrophotometric (AAS) analysis of the mineral element composition of the seeds showed an appreciable amount of macro and micro elements that are required for the growth in humans and animals [21]. Minerals such as calcium (8.92 mg/L), magnesium (0.44 mg/L), potassium (4.26 mg/L), iron (0.22 mg/L), manganese (0.19 mg/L), zinc (1.38 mg/L), and sodium (4.70 mg/L) were present in appreciable quantity. This indicates the importance of the plant in building strong bones, the production of energy, and carrying out some metabolic reactions in the body [21]. Previous scholarly articles documented the isolation of three furanoditerpenes (columbin, isocolumbine, and fibeucin) (Figure 4) and alkaloids (protoberberine) from the fruit [22].

5. Pharmacological and Biological Activities

5.1. Anti-Diabetic Activity

Investigation of the different extracts of morphological organs of S. jollyanum indicated its blood glucose lowering potential. The effect of petroleum ether seed extract on oral glucose tolerant test (OGTT) and alloxan-induced diabetic rabbits revealed that 1 g/kg of the extract administered 30 min before glucose load considerably reduced blood glycemic level by 20% relative to the untreated group. The study also reported the anti-hyperglycemic activity of the extract on alloxan-induced diabetic rabbits [29]. In another study, a 9-day treatment regimen revealed that the extract caused a significant (p < 0.05) dose-dependent decrease in the plasma glucose level from the 3rd to the 9th day. The three-dosage group showed a peak percentage decrease of 12.3%, 29.2%, and 32.7%, which compared favorably with glinbenclamide at 51.9%. Furthermore, the aqueous root extract demonstrated a dose-dependent reduction in blood glycemic level of alloxan-induced diabetic rabbits [30]. Ethanol extracts of S. jollyanum leaf at concentrations of 50, 100, 200 mg/kg significantly (p < 0.05) lowered the blood glycemic index of alloxan-induced diabetic rabbits in a dose-dependent manner, with plasma glucose level of 200.2 mg/100 mL (42.8%) at 200 mg/kg [31]. Alese et al. [32] reported that the methanol root extract demonstrated hypoglycemic effects on streptozotocin-induced diabetic Wistar rats. Oral dosage of 200 mg/kg extracts for 2 weeks caused a significant decrease in blood glucose to 6.62 mmol/L relatively to the uncontrolled group with blood glucose level of 16.3 mmol/L. The results of these studies validate the traditional claim of the blood glucose lowering activity of the plant, and thus may serve as a potential source of potent anti-diabetic compounds.

5.2. Antioxidant Activity

Studies on superoxide radical and hydrogen peroxide scavenging ability of the methanolic stem extract revealed a dose-dependent anti-oxidant activity with IC50 value of 13.11 μg/mL and 30.04 μg/mL when compared to ascorbic acid 15.34 μg/mL and 35.44 μg/mL respectively [23]. In a separate study, Olorunnisola and Afolayan[24] reported that the plant significantly (p < 0.05) ameliorated the oxidative stress related with P. berghei infection in mice, which was evident in the reduced levels of total protein and liver MDA (malondialdehyde). In addition, there was increased activity of serum and liver catalase (CAT), superoxide dismutase (SOD) and glutathione (GSH) levels. Alternatively, Nia et al. [4] point to the anti-oxidant activity of extracts of all morphological organs on 2,2-diphenyl-1-picrylhydrazyl hydrate (DPPH). The stem bark was observed to be the most active with IC50 of 1.80 μg/mL, when compared with ascorbic acid 0.80 μg/mL. The leaf had the weakest activity, IC50 of 4.35 μg/mL, while IC50 of the root bark was 3.50 μg/mL. Fractions of the stem bark were screened, and the chloroform fraction exhibited the most potent activity with an IC50 of 1.54 μg/mL. The findings emanating from these studies indicate the potential of S. jollyanum as an anti-oxidant (Table 2), and thus could be explored in the development of new pharmaceuticals.

5.3. Anti-Inflammatory

Studies on the in vivo anti-inflammatory activity of S. jollyanum crude extracts and isolated compounds were investigated in healthy adult rats inoculated with carrageenan [22]. It was reported that the methanol fruit extract at a concentration of 200 mg/kg showed the stronger inhibition (79.58%) of oedema formation on hind paws, while root extract demonstrated a 53.75% inhibition. The same study also revealed that three furanoditerpenes (namely columbin, isocolumbine, and fibleucin) isolated from the methanolic fruit extract demonstrated considerable anti-inflammatory potentials. Columbin and flavonoids-rich fraction at 200 mg/kg exhibited 67.08% and 76.25% anti-inflammatory activities that were in a comparable range with acetylsalicylic acid. Olorunnisola et al. [27,28] evaluated the in vitro inflammatory potential and possible modes of action of crude extracts and secondary metabolites of S. jollyanum organs. The results also provided some vindication for the traditional usage of S. jollyanum in managing inflammatory-related diseases in the West African sub-region.

5.4. Anti-Allergy Activities

The anti-allergic study was performed on milk-induced leukocytosis and oesinophilia in mice. The ethanolic fruit extracts demonstrated a considerable dose-dependent decrease in the absolute eosinophil and lymphocyte counts. The results suggested the anti-allergy property of the fruit extract, and the mode of activity may involve multiple mechanisms due to phytochemical interactions [36].

5.5. Anti-Malarial Activities

Anti-malarial studies on the leaf and root extracts of S. jollyanum were reported by Olorunnisola in [24,34] respectively. The in vivo anti-plasmodial activity of methanol extracts was evaluated using chloroquine-resistant Plasmodium berghei NK67 strain-inoculated Swiss albino mice. The leaf and root extracts demonstrated statistically significant concentration-dependent activities of (74.4%) and (54.1%), respectively. However, the standard drug arthemether-lumefartrin had a better antimalaria activity (81.4%). Further research is necessary to identify and characterize the active components and determine the possible mode of activity.

5.6. Anti-Bacterial Activities

Aboaba and Ekundayo [20] studied the essential oil composition of the root extract of S. jollyanum against Bacillus subtilis, Salmonellatyphi, Staphylococcus aureus, Bacillus cereus, Proteus mirabilis, and Pseudomonas aeruginosa. It was observed that the essential oil was effective against Bacillus subtilis and Pseudomonas aeruginosa strains with inhibition zones of 10 mm and 9.0 mm, respectively, at 1000 μg/mL. In a separate study, Koleosho et al. [25] showed the plant extract to be a potent inhibitor of S. typhi. The moderate antimicrobial activity displayed supports the traditional use of the root as a laxative which aids proper bowel movements and digestion.

5.7. Anti-Viral Activities

Moody et al. [37,38] revealed that the methanol extracts of the different morphological parts were assessed for their antiviral activities on polio virus Types 1, 2, and 3. It was observed from the study that the leaf and root extracts were active against polio virus Type 2. Additionally, hexane and methanol extracts were investigated and reported for their mosaic virus inhibitory potentials in cowpea.

5.8. Haematological Activities

Methanol root and leaf extracts of S. jollyanum were investigated for possible hematopoietic activity in Wistar mice infected with chloroquine-resistant Plasmodium berghei NK67. Methanol extracts of leaf and root were administered orally for 7 days. The study revealed that there was a significant increase in the pack cell volume (PCV), mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCHC), and hemoglobin (Hb). There was also an observable elevation in red and white blood cell levels, with the exception of monocytes and neutrophils. The study is suggestive of the ability of the extract to stimulate hematopoietic stem cells [22,23,26].

5.9. Effect on Weight

The effect of leaf and root extracts on weight change was investigated in malaria and diabetic rat. It was observed that there was a significant (p < 0.05) increase in weight gain in Wistar mice treated with the extracts. Comparative analysis suggested that the extracts significantly prevented loss of weight in a concentration-dependent pattern in the extract-administered group when compared to the negative control [24,26,33,35]. Consequently, the physical status of the extract-treated animals was improved. This may be related to the ameliorative effect of the extracts to prevent the acute fluid loss, fat catabolism, and protein catabolism which are evident in weight loss.

5.10. Hepatoprotective and Toxicological Studies

Scientific examination of the hepatoprotective potential of stem bark extract revealed that the extract significantly ameliorated/prevented liver damage in carbon tetrachloride (CCl4)-induced rats. The study showed that the extract considerably (p < 0.05) reversed the elevated aspartate aminotransferase (AST), alkaline phosphatase (ALP), alanine amino transferase (ALT), and total bilirubin, and decreased the level of total serum protein in a concentration-dependent pattern [23]. In the submission of Mbaka et al. [26,33], no mortality or morbidity was recorded in the 120-days administration of ethanol leaf extract during the toxicity studies. Detailed assessment also indicated that there was no obvious inflammation of the internal organs. In addition, there were no appreciable increases in serum AST and ALT in the extract-administered animals. This observation denotes that the extract poses no damaging effect on the liver. The result of the histological study on the liver tissue morphology confirmed that no toxic effects of the extract were visible. Furthermore, minimum cytotoxic dose (MCD50) of the methanol leaf extract was also investigated on Hep-2 (Human epithelia cell line) and it was found to range within 3.9 × 10−3 mg/mL [37]. The Ames microbial mutagenicity test of the root ethanol extract showed no statistically observable increase in the number of revertant colonies in the four strains of S. typhimurium TA97, TA98, TA100, and TA102 at any concentration. This indicates that S. jollyanum has no ability to cause mutation in relation to the in vitro assay [19]. According to Aboaba and Ekundayo [20], the toxicity of the essential oil of S. jollyanum to brine shrimp lethality test showed a lethal concentration LC50 of 84.87 ppm. Therefore, the observed safety level of the plant extracts vindicates its age-long ethno-pharmacological usage.

5.11. Hypolipidemic Activity

Effect of the ethanol root extract on serum lipid profile was investigated on streptozotocin-induced diabetic albino rats. It was noticed that there was no observable difference in total cholesterol (TC) amount of the extract- and glinbenclamide-administered animals. Additionally, there was a significant (p < 0.02) difference in antiartherogenic index (AAI) and high-density lipoprotein level in extract-treated group (0.77 ± 0.02 mmol/L) when compared to untreated infected group (0.85 ± 0.02 mmol/L) [32].

5.12. Antidepressant Activity

The anti-depressant effect of the ethanol extract of the root was evaluated on mice using forced swimming and tail suspension examination. The plant extract (100–1000 mg/kg) increased the duration of mobility in both models in a concentration-dependent manner. However, it was observed that the standard drugs imipramine and fluoxetine were 20–50 times more potent than the extracts. This implied that the antidepressant activity of the extract might be as a result of its modifying activity on monoamine transport and metabolism [39].

5.13. Anxiogenic Activity

Anxiogenic activity was carried out by administration of 100–1000 mg/kg of the ethanol extract. The animals exhibited anxiety-like effects dose-dependently in a similar way to those induced by caffeine (10–100 mg/kg), and this was in contrast to the anxiolytic effect of diazepam (0.1–1 mg/kg) [40,41]. The result validates the conventional use of the plant for its stimulatory effect on the central nervous system and as mood enhancer.

5.14. Anti-Angiogenic Activity

Angiogenesis has been reported as a fundamental process in the transition of benign tumors to malignant ones, and therefore Nia et al. [4] evaluated the anti-angiogenic activities of the methanol extract of morphological organs using in vivo chick chorioallantoic membrane (CAM) angiogenesis assay. It was revealed that the stem bark had the most potent activity, with an IC50 value of 1.00 μg/mL. In addition, the chloroform fraction of the stem bark exhibited the strongest inhibitory IC50 (1.54 μg/mL) activity against the formation of new endothelial cells [4], thus validating the ethno-botanical usage of S. jollyanum as an important anti-tumor agent.

5.15. Antipyretic and Analgesic Activities

Muko et al. [42] disclosed that the petroleum ether and methanol extracts of S. jollyanum leaves possess significant in vitro analgesic and antipyretic activities.

5.16. Reproductive and Sexual Activity

Investigation on the potential of the plant extracts to affect sexual activities and hormonal levels in laboratory animals was carried out by Owiredu et al. [43]. It was observed that there was an increased urge by the male animals to mount on the female for the first time, increased duration of ejaculation, and shortened refractory period. Furthermore, a decrease in post-ejaculatory, climbing and intromission latency was observed in the extract-treated animals. These are relevant perceptions of sexual performance and satisfaction. In addition, testosterone level was increased by four-fold and about there was a one-third increment in follicle stimulating hormone (FSH) activity. However, there was a contradictory report by Raji et al. [44] that pointed to a considerable reduction in the total sperm count, fertilization ability of the sperm cells, movement and swimming (asthenozoospermia) abilities. There was also a considerable increase in superoxide dismutase activity in relation to the testes and degeneration of seminiferous tubules. However, it was suggested that S. jollyanum could produce deleterious effects on reproductive ability, which can be measured as a function of poor sperm quantity (epididymal sperm count), quality (sperm movement, viability, structure), and gradual impairment, loss of function of the tissues and cells of the testes.

6. Conclusions

The importance of S. jollyanum in the traditional medicinal system of Africa cannot be over-emphasized. The medicinal value of the plant is owed to it richness in alkaloids, tannins, saponins, flavonoids, and essential oils. These bioactive principles have been reported to be responsible for the various pharmacological efficacies reported in this review. Hence, all morphological organs of the plant stand an important chance as a major source of potent therapeutic compounds useful in the management of several human diseases.

Author Contributions

O.S.O. conceived the idea and outlined the content, O.S.F. and P.A. searched the internet and wrote the manuscript. All authors read and approved the final manuscript for submission.

Conflicts of Interest

Authors declare there is no conflict of interest.

References

  1. Tiwari, A.K.; Mehta, R. Medicinal plants used by traditional healers in Jashpur district of Chhattisgarh India. Life Sci. Leafl. 2013, 1, 31–41. [Google Scholar]
  2. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012, 75, 311–335. [Google Scholar] [CrossRef] [PubMed]
  3. Farnsworth, N.R.; Akerele, O.; Bingel, A. Medicinal plants in therapy. Bull. World Health Organ. 1985, 63, 965–981. [Google Scholar]
  4. Nia, R.; Paper, D.H.; Essien, E.E. Evaluation of the anti-oxidant and anti-angiogenic effects of Sphenocentrum jollyanum Pierre. Afr. J. Biomed. Res. 2004, 7, 129–132. [Google Scholar]
  5. Amidu, N. An Evaluation of the Central and Sexual Behavioral Effects and Toxicity of the Root Extract of Sphenocentrum jollyanum Pierre (Menispermaceae). Ph.D. Thesis, Department of Molecular Medicine, Kwame Nkrumah University of Science & Technology, Kumasi, Ghana, 2008. [Google Scholar]
  6. Dalziel, J.M. The Useful Plants of West Tropical Africa; Crown Agents: London, UK, 1985. [Google Scholar]
  7. Iwu, M.M. Handbook of African Medicinal Plants; CRC Press: Boca Raton, FL, USA, 1993; p. 239. [Google Scholar]
  8. Abbiw, D.K. Useful Plants of Ghana; Intermediate Technology Publications and Royal Botanic Gardens: Kew, UK, 1990. [Google Scholar]
  9. Neuwinger, H.D. African Ethno Botany: Poisons and Drugs; Chapman and Hall: London, UK, 1996. [Google Scholar]
  10. Irvine, F.R. Woody Plants of Ghana: With Special Reference to the Uses; Oxford University Press: London, UK, 1961. [Google Scholar]
  11. Burkill, H.M. Volume 1: The Useful Plants of West Tropical Africa; Royal Botanical Gardens: Kew, UK, 1985. [Google Scholar]
  12. Oke, J.M.; Hamburger, M.O. Screening of some Nigeria medicinal plant Antioxidant Acitivity Using 22-Diphenyl-picryl-hydrazyl radical. Afr. J. Biomed. Res. 2002, 5, 77–79. [Google Scholar]
  13. Odugbemi, T. Medicinal Plants by Species Names: Outlines and Pictures of Medicinal Plants from Nigeria; Lagos University Press: Ojo, Lagos State, Nigeria, 2006. [Google Scholar]
  14. Oliver-Bever, B. Medicinal Plants in Tropical West Africa; Cambridge University Press: Cambridge, UK, 1986. [Google Scholar]
  15. Kayode, J.; Ige, O.E.; Adetogo, T.A.; Igbakin, A.P. Conservation and Bio derversity in Ondo State, Nigeria. Survey of plant barks used in native pharmaceutical extraction in Akoko region. EthnoBot. Leafl. 2009, 13, 665–667. [Google Scholar]
  16. Fasola, T.R.; Egunyomi, A. Bark extraction and uses of some medicinal plants. Niger. J. Biotechnol. 2002, 15, 23–36. [Google Scholar]
  17. Ghana Herbal Pharmacopoeia. Ghana Herbal Pharmacopoeia; Advent Press: Accra, Ghana, 1992. [Google Scholar]
  18. Egunyomi, A.; Fasola, T.R.; Oladunjoye, O. Charring Medicinal Plants: A Traditional Method of Preparing Phytomedicines in Southwestern Nigeria. EthnoBot. J. 2005, 3, 261–265. [Google Scholar] [CrossRef]
  19. Amidu, N.; Woode, E.; Owiredu, K.B.; William, A.; George-Boateng, A.K.; Opoku-Okrah, C. An Evaluation of Toxicity and Mutagenicity of Sphenocentrum jollyanum. Int. J. Pharm. 2008, 4, 67–77. [Google Scholar]
  20. Aboaba, S.A.; Ekundayo, O. Constituents, antibacterial activities and toxicological assay of essential oils of Artocarpus communis Forst (Moraceae) and Sphenocentrum jollyanum (Menispermaceae). Int. J. Biol. Chem. Sci. 2010, 4, 1455–1461. [Google Scholar] [CrossRef]
  21. Ibironke, A.A.; Olusola, O.O. Phytochemical analysis and mineral element composition of ten medicinal plant seeds from South-west Nigeria. N. Y. Sci. J. 2013, 6, 2–28. [Google Scholar]
  22. Moody, J.O.; Robert, V.A.; Connolly, J.D.; Houghton, P.J. Anti-inflammatory activities of the methanol extracts and an isolated furanoditerpene constituent of Sphenocentrum jollyanum Pierre (Menispermaceae). J. Ethnopharmacol. 2006, 104, 87–91. [Google Scholar] [CrossRef] [PubMed]
  23. Olorunnisola, O.S.; Akintola, A.A.; Afolayan, A.J. Hepatoprotective and antioxidant effect of Sphenocentrum jollyanum (Menispermaceae) stem bark extract against CCl4-induced oxidative stress in rats. Afr. J. Pharm. Pharmacol. 2011, 5, 1241–1246. [Google Scholar] [CrossRef]
  24. Olorunnisola, O.S.; Afolayan, A.J. In Vivo antioxidant and biochemical evaluation of Sphenocentrum jollyanum leaf extract in P. berghei infected mice. Pak. J. Pharm. Sci. 2013, 26, 445–450. [Google Scholar] [PubMed]
  25. Koleosho, A.T.; Jose, A.R.; Oyibo, P.G.; Roland-Ayodele, M.A.; Uloko, M.E. Antimicrobial Activity of Sphenocentrum jollyanum and Mangifera indicaLinn On Salmonella Typhi. Pak. J. Pharm. Sci. 2013, 5, 50–54. [Google Scholar]
  26. Mbaka, G.O.; Adeyemi, O.O.; Oremosu, A.A. Acute and sub-chronic toxicity studies of the ethanol extract of the leaves of Sphenocentrum jollyanum (Menispermaceae). Agric. Biol. J. N. Am. 2010, 1, 265–272. [Google Scholar] [CrossRef]
  27. Olorunnisola, O.S.; Fadahunsi, O.; Adetutu, A.; Olasunkanmi, A. Evaluation of Membrane Stabilizing, Proteinase and Lipoxygenase Inhibitory Activities of Ethanol Extract of Root and Stem of Sphenocentrum jollyanum Pierre. J. Adv. Biol. Biotechnol. 2017, 13, 1–8. [Google Scholar]
  28. Olorunnisola, O.S.; Fadahunsi, O.S.; Owoade, O.A. In Vitro anti-inflammatory activities of extracts of the leaves of Sphenocentrum jollyanum Pierre. J. Appl. Life Sci. Int. 2017. accepted. [Google Scholar]
  29. Mbaka, G.O.; Adeyemi, O.O.; Adesina, S.A. Anti-diabetic activity of the seed extract of Sphenocentrum jollyanum and morphological changes on pancreatic beta cells in alloxan-induced diabetic rabbits. J. Med. Med. Sci. 2010, 1, 550–556. [Google Scholar]
  30. Mbaka, G.; Adeyemi, O.; Osinubi, A.; Noronha, C.; Okanlawon, A. The effect of aqueous root extract of Sphenocentrum jollyanum on blood glucose level of rabbits. J. Med. Plants Res. 2009, 3, 870–874. [Google Scholar]
  31. Mbaka, G.O.; Adeyemi, O.O.; Anunobi, C.C. Anti-hyperglycemic effects of ethanol leaf extract of Sphenocentrum jollyanum in normal and alloxan-induced diabetic rabbits. Glob. J. Pharmacol. 2008, 2, 46–51. [Google Scholar]
  32. Alese, M.O.; Adewale, O.S.; Ijomone, O.M.; Ajayi, S.A.; Alese, O.O. Hypolipidemic and hypoglycemic activities of methanol extract of Sphenocentrum jollyanum on stretozocin induced diabetic Wistar rats. Eur. J. Med. Plants 2014, 4, 353–364. [Google Scholar] [CrossRef]
  33. Mbaka, G.O.; Owolabi, M.A. Evaluation of Haematinic Activity and Sub chronic Toxicity of Sphenocentrum jollyanum (Menispermaceae) Seed Oil. Eur. J. Med. Plants 2011, 1, 140–152. [Google Scholar] [CrossRef]
  34. Olorunnisola, O.S.; Afolayan, A.J. In Vivo antimalaria of methanol leaf and root extracts Sphenocentrum jollyanum. Afr. J. Pharm. Pharmacol. 2011, 5, 1669–1673. [Google Scholar] [CrossRef]
  35. Mbaka, G.O.; Adeyemi, O.O.; Ogbonnia., S.O.; Noronha, C.C.; Okanlawon, O.A. The protective effect of ethanol root extract of Sphenocentrum jollyanum on the morphology of pancreatic beta cells of alloxan challenged rabbits. J. Morphol. 2011, 28, 37–45. [Google Scholar]
  36. Olorunnisola, O.S.; Adetutu, A.; Fadahunsi, O.S. Anti-allergy potential and possible modes of action of Sphenocentrum jollyanum Pierre fruit extracts. J. Phytopharm. 2017, 6, 20–26. [Google Scholar]
  37. Moody, J.O.; Robert, V.A.; Adeniji, J.A. Anti-viral effect of selected medicinal plants: Diospyros bateri, D. monbutensis and Sphenocentrum jollyanum on polio viruses. Niger. J. Nat. Prod. Med. 2002, 6, 4–6. [Google Scholar]
  38. Moody, J.O.; Robert, V.A.; Hughes, J.A. Anti-viral activities of selected medicinal plantsand effect of extracts of Diospyrosmon butensis and Sphenocentrum jollyanum on cowpea mosaic viruses. Pharm. Biol. 2002, 40, 342–345. [Google Scholar] [CrossRef]
  39. Woode, E.; Amidu, N.; Owiredu, K.; Boakye, G.; Ansah, C.; Duweijua, M. Antidepressant–Like effects of an ethanol extract of Sphenocentrum jollyanum Pierre Roots in Mice. Int. J. Pharmacol. 2009, 5, 22–29. [Google Scholar] [CrossRef]
  40. Woode, E.; Duwiejua, M.; Ansah, C.; Kuffour, G.A.; Obiri, D.D.; Amidu, N. Effect of Sphenocentrum jollyanum in experimental mouse models of anxiety. In Proceedings of the 2nd Western Africa Network of Natural Products Research Scientists (WANNPRES), Elmina 32, Ghana, 1–4 August 2006; p. 32. [Google Scholar]
  41. Woode, E.; Amidu, N.; Owiredu, K.; Boakye, G.; Laing, E.F.; Ansah, C.; Duweijua, M. Anxiogenic—Like effect of a root extract of Sphenocentrum jollyanum Pierre in Murine behaviour models. J.Pharmacol. Toxicol. 2009, 4, 91–108. [Google Scholar] [CrossRef]
  42. Muko, K.N.; Ohiri, P.C.; Ezugwu, C.O. Antipyretic and analgesic activities of Sphenocentrum jollyanum. Niger. J. Nat. Prod. Med. 1998, 2, 52–53. [Google Scholar]
  43. Owiredu, W.A.; Amidu, N.; Amissah, F.; Woode, E. The effects of ethanol extract of root of Sphenocentrum jollyanum Pierre on sexual behavior and hormonal levels in rodents. J. Sci. Technol. 2007, 27, 9–21. [Google Scholar]
  44. Raji, Y.; Fadare, O.O.; Adisa, R.A.; Salami, S.A. Comprehensive assessment of the effect of Sphenocentrum jollyanum root extract on male albino rats. Reprod. Med. Biol. 2006, 5, 283–292. [Google Scholar] [CrossRef]
Figure 1. Sphenocentrum jollyanum in its natural habitat.
Figure 1. Sphenocentrum jollyanum in its natural habitat.
Medicines 04 00050 g001
Figure 2. Sphenocentrum jollyanum fruits.
Figure 2. Sphenocentrum jollyanum fruits.
Medicines 04 00050 g002
Figure 3. Some identified compounds from the root oil of S. jollyanum.
Figure 3. Some identified compounds from the root oil of S. jollyanum.
Medicines 04 00050 g003
Figure 4. Isolated compounds from fruits of S. jollyanum. Structure of isolated fibleucin (a) and isocolumbin (b) [22], Structure of isolated columbine (c) [22].
Figure 4. Isolated compounds from fruits of S. jollyanum. Structure of isolated fibleucin (a) and isocolumbin (b) [22], Structure of isolated columbine (c) [22].
Medicines 04 00050 g004
Table 1. Taxonomical classification of Sphenocentrum jollyanum [5].
Table 1. Taxonomical classification of Sphenocentrum jollyanum [5].
KingdomPlantae
DivisionMagnoliophyta (Cronquist)
SubdivisionMagnoliophytina (Frohne and Jensen)
ClassRanunculopsida (Brongn)
SubclassRanunculidae (Takht)
SuborderRanunculanae (Takht)
OrderMenispermales (Bromhead)
FamilyMenispermaceae (Juss.)
GenusSphenocentrum (Pierre)
SpeciesJollyanum
Table 2. Summary of pharmacological activities of S. jollyanum.
Table 2. Summary of pharmacological activities of S. jollyanum.
Pharmacological ActivitiesPart UsedExtractsReferences
AngiogenicStem bark, Methanol, Chloroform [4]
Anti-Oxidant Stem bark, Root, LeafMethanol, Hexane, Chloroform, Ethanol, Butanol, Aqueous [4,23,24]
Anti-BacteriaRootEssential oil, Ethanol [20,25]
HaematologicalLeaf , RootMethanol[22,23,26]
Anti-InflammatoryFruit, Root,Methanol, Ethanol, Aqueous[22,27,28]
Anti-DiabeticRoot, Stem, Fruit, LeafAqueous, Ethanol, Methanol [29,30,31,32]
HypolipidemicRootEthanol[32]
Hepatoprotective,Toxicological Stem bark, Leaf, Root, Methanol, Ethanol, Essential oil [23,26,33]
Anti-MalariaLeaf, RootMethanol[24,34]
Weight Loss PreventionLeaf , Root, Seed Ethanol, Essential oil[24,26,33,35]
Anti-AllergyFruitEthanol[36]
Anti-viralStem, Root, LeafHexane, Methanol[37,38]
Anti-depressant RootEthanol[39]
AnxiogenicRootEthanol[40,41]
Analgesic, AntipyreticLeafMethanol[42]
Sexual, ReproductiveRootEthanol, Methanol[43,44]

Share and Cite

MDPI and ACS Style

Olorunnisola, O.S.; Fadahunsi, O.S.; Adegbola, P. A Review on Ethno-Medicinal and Pharmacological Activities of Sphenocentrum jollyanum Pierre. Medicines 2017, 4, 50. https://doi.org/10.3390/medicines4030050

AMA Style

Olorunnisola OS, Fadahunsi OS, Adegbola P. A Review on Ethno-Medicinal and Pharmacological Activities of Sphenocentrum jollyanum Pierre. Medicines. 2017; 4(3):50. https://doi.org/10.3390/medicines4030050

Chicago/Turabian Style

Olorunnisola, Olubukola Sinbad, Olumide Samuel Fadahunsi, and Peter Adegbola. 2017. "A Review on Ethno-Medicinal and Pharmacological Activities of Sphenocentrum jollyanum Pierre" Medicines 4, no. 3: 50. https://doi.org/10.3390/medicines4030050

APA Style

Olorunnisola, O. S., Fadahunsi, O. S., & Adegbola, P. (2017). A Review on Ethno-Medicinal and Pharmacological Activities of Sphenocentrum jollyanum Pierre. Medicines, 4(3), 50. https://doi.org/10.3390/medicines4030050

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop